Clinical Trial Update: DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing topical versus intravenous tranexamic acid to reduce postoperative blood loss in open cardiac surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Cardiac Surgery
• Surgical Blood Loss

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Population Health Research Institute | Conditions: Bleeding, Surgical Blood Loss | Phase 3 | Status: TERMINATED